| Trial ID: | L0931 |
| Source ID: | NCT01680640
|
| Associated Drug: |
Synbiotic
|
| Title: |
Investigation of the Effects of a Synbiotic on Liver Fat, Disease Biomarkers and Intestinal Microbiota in Non-alcoholic Fatty Liver Disease
|
| Acronym: |
INSYTE
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Synbiotic;Dietary Supplement: Maltodextrin
|
| Outcome Measures: |
Change in biomarkers for NAFLD and change in liver fat;Change in biomarkers for NAFLD and change in liver fat;Change in biomarkers for NAFLD and change in liver fatChange in adipose tissue inflammation, satiety and risk factors for type 2 diabetes.;Change in adipose tissue inflammation, satiety and risk factors for type 2 diabetes.;Change in adipose tissue inflammation, satiety and risk factors for type 2 diabetes.;Change in adipose tissue inflammation, satiety and risk factors for type 2 diabetes.;Change in adipose tissue inflammation, satiety and risk factors for type 2 diabetes.;Change in adipose tissue inflammation, satiety and risk factors for type 2 diabetes;Change in adipose tissue inflammation, satiety and risk factors for type 2 diabetes.
|
| Sponsor/Collaborators: |
University Hospital Southampton NHS Foundation Trust
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
| Start Date: |
24/08/2012
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT01680640
|
